Status:
COMPLETED
Laser Tongue Debridement for Oral Malodor
Lead Sponsor:
New York Head & Neck Institute
Collaborating Sponsors:
Biolase Inc
Ohio State University
Conditions:
Halitosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Malodor is a multifactorial condition with oral pathology representing the main culprit and the tongue being the first to second contributor to the malodor. Bacterial load can represent a quantifiable...
Eligibility Criteria
Inclusion
- an individual (male or female) who can understand and voluntarily sign an informed consent form
- a baseline organoleptic oral malodor score of at least 2
Exclusion
- severe caries,
- signs of gingival inflammation on intraoral exam
- possible extra-oral halitosis (tonsillitis, sinusitis, and pulmonary pathologic conditions, or a condition that may contribute to systemic halitosis, such as hepatic cirrhosis or uncontrolled diabetes)
- antibiotic treatment within 1 month prior to study
- pregnant
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04120948
Start Date
August 1 2018
End Date
October 1 2018
Last Update
October 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Head & Neck Institute offices
New York, New York, United States, 10019